Cite
HARVARD Citation
Pak, T. et al. (2022). Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience. Leukemia & lymphoma. 63 (4), pp. 876-884. [Online].